Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance
Acadia Healthcare reported Q3 2026 revenue of $895.3 million, up 5.1% year-over-year, with same-facility revenue growth of 5.2% on 4.0% higher revenue per patient day. Profitability was weaker: net income of $34.5 million ($0.38 diluted EPS) and adjusted EPS of $0.60 both declined from the prior year, though Adjusted EBITDA rose to $176.4 million from $173.0 million. The company raised full-year 2026 guidance across the board -- Adjusted EBITDA to $615-$625 million from $590-$615 million and adjusted EPS to $1.70-$1.80 from $1.45-$1.60.
Key figures
- Eps
- 0.38
- Revenue
- 895300000
- Guidance
- FY2026 revenue $3.44-$3.46B (from $3.40-$3.45B); Adjusted EBITDA $615-$625M (from $590-$615M); Adjusted EPS $1.70-$1.80 (from $1.45-$1.60); Operating cash flow $375-$400M; capex $210-$230M
- Revenue Yoy
- 5.1%
- Cash
- 163300000
- Net income
- 34500000
- Adjusted eps
- 0.6
- Capex quarter
- 50700000
- Adjusted ebitda
- 176400000
- Net leverage ratio
- 3.9x Adjusted EBITDA
- Licensed beds added
- 220
- Adjusted eps prior year
- 0.72
- Operating cash flow quarter
- 97900000
- Same facility revenue growth
- 5.2%
- Incremental de novo ebitda 2027
- $60M expected
- Florida supplemental payment benefit
- $13.4M vs $5.6M in prior guidance
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.